Stocks and Investing Stocks and Investing
Thu, February 17, 2011
[ 09:20 AM ] - WOPRAI
ACMR SqueezeTrigger Price is $2.937. There is $260528.00 That Short Sellers Still Need To Cover.
[ 09:14 AM ] - WOPRAI
Skechers USA (SKX) Up After BUYINS.NET Report Predicted Strength After Earnings
[ 09:07 AM ] - WOPRAI
Cliffs Natural Resources (CLF) Up After BUYINS.NET Report Predicted Strength After Earnings
[ 09:04 AM ] - WOPRAI
Ensign Group (ENSG) Up After BUYINS.NET Report Predicted Strength After Earnings
[ 09:00 AM ] - WOPRAI
Energy Transfer Partners (ETP) Down After BUYINS.NET Report Predicted Weakness After Earnings
[ 08:57 AM ] - WOPRAI
Health Care REIT (HCN) Down After BUYINS.NET Report Predicted Weakness After Earnings
[ 08:53 AM ] - WOPRAI
InterMune (ITMN) Down After BUYINS.NET Report Predicted Weakness After Earnings
[ 08:50 AM ] - WOPRAI
Vectren Corp (VVC) Down After BUYINS.NET Report Predicted Weakness After Earnings
[ 08:44 AM ] - WOPRAI
Energy Transfer Equity (ETE) Down After BUYINS.NET Report Predicted Weakness After Earnings
[ 08:41 AM ] - WOPRAI
CyberOptics (CYBE) Down After BUYINS.NET Report Predicted Weakness After Earnings
[ 08:38 AM ] - WOPRAI
Cray Computer (CRAY) Down After BUYINS.NET Report Predicted Weakness After Earnings
[ 08:34 AM ] - WOPRAI
EnerNOC (ENOC) Down After BUYINS.NET Report Predicted Weakness After Earnings
[ 08:30 AM ] - Market Wire
ITT to Highlight ISR, Tactical Communications and .. re Solutions at 2011 IDEX Conference in Abu Dhabi
[ 08:00 AM ] - WOPRAI
QCOR, PZZA, SLTM, HS Expected To Be Up Before Next Earnings Releases
[ 08:00 AM ] - WOPRAI
KONG, EXAC, MINI, LYV, GPS, EDGR Expected To Be Up Before Next Earnings Releases
[ 08:00 AM ] - WOPRAI
ULTR, MCS, IILG, NOVL, BIG, CYBX Expected To Be Up Before Next Earnings Releases
[ 07:50 AM ] - WOPRAI
ENP, PGN Expected To Be Down Before Next Earnings Releases
[ 07:50 AM ] - WOPRAI
CETV, ANDS, WIRE, FRO, WAB, EPIQ Expected To Be Down Before Next Earnings Releases
[ 07:50 AM ] - WOPRAI
SALM, BKR, ORN, SQM, DDSS, EXM Expected To Be Down Before Next Earnings Releases
[ 07:40 AM ] - WOPRAI
HMSY, PNW, NVE, BAM Expected To Be Up After Next Earnings Releases
[ 07:40 AM ] - WOPRAI
NCBC, PGN, AGP, CPB, SFL, LPNT Expected To Be Up After Next Earnings Releases
[ 07:30 AM ] - WOPRAI
CPN, CRFN, HPT, ECBE, TA, YGE Expected To Be Down After Next Earnings Releases
[ 07:21 AM ] - Market Wire
Integra Gold Commences 20,000 Meter Drill Program at Lamaque
[ 07:20 AM ] - WOPRAI
NBH SqueezeTrigger Price is $13.879. There is $592200.00 That Short Sellers Still Need To Cover.
[ 06:50 AM ] - Market Wire
Exploration targed defined at Webbs Silver Project
[ 06:10 AM ] - WOPRAI
XLFS, Added To Naked Short Lists Today
[ 06:10 AM ] - WOPRAI
ZIOP, CHGI, Has Remained On Naked Short Lists 13 Consecutive Days
[ 06:10 AM ] - WOPRAI
MLKKF, CIBEY, ECTE, Removed From Naked Short Lists Today
[ 05:20 AM ] - WOPRAI
TKC SqueezeTrigger Price is $15.931. There is $25906083.00 That Short Sellers Still Need To Cover.
[ 05:00 AM ] - Market Wire
Fibrocell Science, Inc. to Present at The Wall Street Analyst Forum 22nd Annual Analyst Conference

Fibrocell Science, Inc. to Present at The Wall Street Analyst Forum 22nd Annual Analyst Conference


Published on 2011-02-17 05:11:01 - Market Wire
  Print publication without navigation


EXTON, Pa.--([ BUSINESS WIRE ])--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Companya™s Chairman and CEO, will be presenting at The Wall Street Analyst Forum 22nd Annual Analyst Conference to be held on Tuesday, March 1, at TheUniversity Club (1 West 54th Street) in NYC.

Fibrocella™s presentation is scheduled for 12:05 p.m. Eastern Time.

The audio portion of the presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at [ www.fibrocellscience.com ].

About Fibrocell Science, Inc.

Fibrocell Science, Inc. (OTCBB: FCSC) is a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence. For additional information, please visit [ www.fibrocellscience.com ].

Contributing Sources